Kidney Disease

Visitors are invited to explore galleries highlighting key discoveries and transformative insights in biomedicine.

A team studying rare kidney diseases pivoted to lung injury and identified an FDA-approved drug that’s now being tested as a potential COVID-19 treatment.

Broad scientists are using brain, kidney, and tumor organoids to gain new insights into disease mechanisms and therapeutic approaches.

Researchers have found 16 new regions in the human genome that are associated with a leading complication of diabetes and point to a possible cause.

Researchers find that several genetic disorders, including MUC1 kidney disease, may share a novel molecular mechanism — and identify a promising therapeutic lead.

Inspired by rare genetic disease, researchers develop a compound that can protect kidney cells from death and restore kidney function in multiple animal models of progressive kidney disease.